Author: admin

In 1851, a small Swiss company began producing collagen-based materials in Wolhusen. That company is Geistlich. What started as Switzerland’s first glue factory grew, over more than a century and a half, into one of the most scientifically credentialed regenerative biomaterials companies in the world. Today, a Geistlich product is used every 14 seconds globally. More than 2,800 peer-reviewed publications underpin their product portfolio. That depth of evidence does not happen by accident.

Synchrocare distributes Geistlich products as part of its national specialty medical device portfolio, giving surgeons and healthcare facilities in the United States access to this technology through trained, compliant medical sales consultants.

Here is what orthopedic and sports medicine surgeons should know about what Geistlich brings to bone and cartilage regeneration.

Geistlich focuses on regenerative, minimally invasive methods and the development of products that support self-healing processes in the body.

Orthoss is Geistlich’s bone graft substitute for orthopedic applications. It is bio-engineered to closely resemble the inorganic component of human bone tissue, with a unique pore structure that mirrors the architecture of natural bone. This internal structure gives Orthoss an inner surface area similar to that of autologous bone, which supports bone regeneration by providing an osteoconductive environment for cell ingrowth.

To repair bone defects, autografts are still widely considered the gold standard, but autografts carry documented risks, including donor site morbidity and limited availability. Orthoss provides an alternative that avoids those trade-offs, is available off the shelf in unlimited quantities, and comes in various sizes and formats. The product has a global history demonstrating safety across orthopedic indications, and has been validated in collaboration with surgeons across multiple clinical settings.

Cartilage repair built on a decade of evidence

Articular cartilage has a limited capacity to heal itself. Without adequate blood supply and with low chondrocyte mitogenic potential, cartilage defects left untreated progress over time and frequently lead to osteoarthritis. Geistlich developed Chondro-Gide to address this directly.

Chondro-Gide is a highly purified collagen membrane with a specifically engineered bilayer structure. The rough, porous bottom layer supports cell colonization and tissue ingrowth. The smooth, compact top layer faces the joint cavity and prevents progenitor cells from diffusing out of the defect site into the joint space, where they would be lost to the regeneration process. The membrane is biocompatible and fully resorbable, replaced by native tissue as healing progresses.

Used in the AMIC technique, Autologous Matrix-Induced Chondrogenesis, Chondro-Gide is applied over a bone marrow stimulation site to create a biological chamber that stabilizes the superclot and provides the conditions for new cartilage tissue to form. AMIC with Chondro-Gide is a single-step, minimally invasive procedure performable by mini-open or arthroscopic methods. Clinical applications include the knee, talus, hip, and first metatarsophalangeal joint.

More than ten years of clinical data support the effectiveness of Chondro-Gide in cartilage repair. A randomized controlled trial published in the International Orthopaedics journal demonstrated sustained benefit of AMIC over microfracture alone at five years. In a three-arm study of 47 patients, pain and function scores for the microfracture-only group deteriorated significantly after two years, while AMIC outcomes remained stable or improved. Geistlich Pharma data on file and published clinical studies.

Chondro-Gide has also received Breakthrough Device Designation from the US Food and Drug Administration, a recognition that the product addresses an unmet clinical need and offers new, more effective treatment options for patients with serious joint conditions.

A Swiss company with a global scientific foundation

Geistlich is a privately held, family-owned Swiss company that has been manufacturing biomaterials of the highest quality in Wolhusen since 1899. The company has 15 international affiliates and a large global distribution network. Its commitment to scientific rigor is formalized through three independent foundations: the Osteology Foundation in dentistry, the Osteo Science Foundation in North America, and the ON Foundation in orthopedics, all dedicated to independent research and education in regenerative medicine.

To learn more about Geistlich products available through Synchrocare, visit www.synchrocare.com.

The strongest medical device territories are not built by the best salespeople. They are built by the people surgeons trust most.

That distinction matters more in medical device sales than in almost any other sales environment. A surgeon who does not trust that a sales consultant understands their patients, their anatomy, and the clinical decisions they are making will not give that consultant meaningful access to their OR. No amount of relationship management compensates for clinical credibility in that room. The representatives who build lasting territories are the ones who think like clinicians, even though they are not.

Clinical thinking is a learnable discipline

Thinking like a clinician in medical device sales does not mean diagnosing patients or advising on surgical technique. It means understanding the anatomy relevant to the procedures your products are used in. It means knowing the clinical indication criteria well enough to support appropriate patient selection conversations. It means being able to discuss the published evidence behind a device, not just its features.

These skills are trainable, and Synchrocare’s medical sales consultant training program builds them deliberately. Every franchise owner completes training on product knowledge, procedure-relevant anatomy, surgical technique considerations, and the full compliance framework before entering the market. That foundation is what separates a Synchrocare franchise owner from a rep who learned the product on the job.

How clinical knowledge builds durable surgeon relationships

Surgeons operate in high-stakes environments where every decision is consequential. When a medical sales consultant brings information that is clinically relevant, grounded in evidence, and delivered with a genuine understanding of what the surgeon is trying to achieve for their patient, the nature of that relationship changes.

It moves from vendor to trusted resource. That shift does not happen through social skills alone. It happens through the kind of clinical knowledge that makes a rep genuinely useful in and around the OR, not just at a lunch meeting. Franchise owners who invest in that knowledge from the beginning build relationships that generate consistent, long-term territory value.

What ownership adds to the equation

A clinically knowledgeable employee and a clinically knowledgeable franchise owner cover the same ground differently. The owner has a stake in every relationship they build. When a surgeon trusts a Synchrocare franchise owner, that trust accrues to a business the owner controls, not to an employer who can reassign the territory on thirty days’ notice.

The Synchrocare franchise model provides the portfolio, the infrastructure, the compliance support, and the purchasing power of a national network. What the franchise owner brings is the clinical credibility and relationship depth that no infrastructure can manufacture. Those two things together are what build a territory worth owning.

The medical device industry rewards that combination generously and consistently. The question is whether you are positioned to receive that reward as an owner or as someone who is building it for someone else.

To learn more about the Synchrocare franchise opportunity, visit www.synchrocare.com/franchising.

Value-based care models tie reimbursement directly to patient outcomes, care quality, and cost efficiency. For hospital systems and ambulatory surgery centers operating under these frameworks, every vendor relationship either contributes to those goals or creates friction against them. A specialty medical device distributor whose clinical standards, product portfolio, and support infrastructure are aligned with outcome-focused care is not just a supplier. It is a partner in the model.

Most procurement decisions treat medical device distribution as a cost center. Value-based care invites a different question: how does this distributor relationship affect the quality of care we deliver and the cost of delivering it?

Devices that support better outcomes reduce the total cost of care

Value-based care frameworks penalize complications, readmissions, and revision surgeries. They reward facilities where patients recover well, return to function faster, and require fewer follow-up interventions. The devices used in those outcomes are not separate from the equation. They are central to it.

Synchrocare selects manufacturer partners whose products address genuine clinical needs, have strong safety profiles, and are supported by clinical evidence. Every device in Synchrocare’s portfolio is FDA-approved and distributed with the clinical support infrastructure needed to ensure appropriate use. That selectivity, choosing fewer products that meet a high standard rather than distributing broadly without clinical depth, is what protects your facility’s outcome data.

Clinical support that reduces complications and follow-up costs

Complications related to inadequate device training and suboptimal patient selection are among the most preventable cost drivers in surgical care. A distributor whose medical sales consultants are comprehensively trained on product knowledge, procedure-relevant anatomy, and appropriate patient selection criteria reduces that risk at the point closest to the patient.

Synchrocare’s medical sales consultants complete rigorous training before entering any facility and remain available for clinical support across the entire lifecycle of a product relationship. Technique guides, case studies, and in-service resources are provided as standard across every product in the portfolio. For administrators tracking complication rates and readmission data, the quality of that clinical support is directly relevant to those numbers.

Compliance infrastructure that protects your institutional standing

Under value-based care contracting, institutional compliance is audited more rigorously than it was under traditional fee-for-service models. Vendor relationships that create compliance exposure, through inadequately trained representatives, missing credentials, or non-standard conduct, carry institutional risk that falls directly on the facility.

Every Synchrocare medical sales consultant undergoes a thorough background check, maintains industry-standard insurance, and is trained on the AdvaMed Code of Ethics, the Stark Law, the Anti-Kickback Statute, and the False Claims Act before entering any facility. All activities are conducted in full compliance with applicable regulations and industry standards. For compliance officers and procurement teams operating under increased scrutiny, that foundation is a meaningful risk reduction.

A distributor relationship built for the long term

Value-based care rewards consistency. Facilities that deliver reliable outcomes over time, supported by stable vendor relationships with high clinical standards, build the kind of performance record that translates into stronger contracting positions and better reimbursement rates. Synchrocare’s model, a selective product portfolio, trained and compliant field representatives, and back-office infrastructure that keeps supply chains reliable, is designed to support exactly that kind of consistency.

To learn more about how Synchrocare supports hospital and ASC value-based care goals, visit www.synchrocare.com.

Before a patient consents to surgery, they ask questions. What is this device made of? Has it been tested? How long has it been used? The surgeon who answers those questions with confidence, grounded in real published evidence, earns a different kind of patient trust from one who gives general reassurance.

That difference starts before the patient interaction. It starts with how deeply a surgeon understands the clinical evidence behind the devices they choose.

Evidence shapes better selection decisions

Knowing that a device has performed well in a published clinical trial is not the same as understanding what that trial measured, in which patient population, and over what follow-up period. Those details determine whether a device is appropriate for the specific patient in front of you.

A surgeon who reads the data, rather than just the summary, understands the indication criteria, the contraindications, and the edge cases where a different choice serves the patient better. That clinical precision is what separates good outcomes from excellent ones across a practice.

Published data as a tool in shared decision-making

Patients today arrive informed, or at least they believe they are. They have read about procedures online. They have seen device advertisements. They have talked to friends who have had similar surgeries. When a surgeon adds published clinical evidence to that conversation, it changes the quality of the decision the patient makes.

Presenting outcome data in plain language, explaining what success rates mean in practical terms, and acknowledging where evidence is strong versus where it is still developing, builds the kind of clinical credibility that patients remember and that drives referrals.

What Synchrocare’s clinical resources deliver

Synchrocare provides clinical support resources across every product in its portfolio. These resources may include peer-reviewed publications, technique guides, case studies, and FAQs. These are not marketing materials. They are the tools surgeons and clinical educators need to stay current on the evidence base for the devices they use.

Medical sales consultants trained by Synchrocare are prepared to discuss the clinical rationale behind each product, not just its features and application steps. When a surgeon has a question about a device’s performance in a specific patient profile, that answer should be available before the case, not after.

Staying current as device portfolios evolve

The evidence base for any device continues to grow after commercial launch. New publications add to or refine what was known at the time of FDA clearance. Technique papers address application nuances. Long-term follow-up studies confirm or qualify early data.

A surgeon who built their device knowledge during initial training, and has not revisited it since, is working from an incomplete picture. Synchrocare’s ongoing clinical support is designed to close that gap, keeping surgical teams current on the evidence that matters most for the patients they treat.

To learn more about Synchrocare’s clinical support resources, visit www.synchrocare.com.

A solo medical device sales rep and a Synchrocare franchise owner often cover the same territory, call on the same surgeons, and compete for the same cases. The difference between them is not effort or clinical knowledge. It is what each one walks into that territory carrying.

The solo rep carries a single company’s product line, their own compliance framework, their own credentialing costs, and their own back-office support, or lack of it. The franchise owner walks in backed by a national network’s purchasing power, an established portfolio of FDA-approved devices across multiple specialties, a proven training program, and infrastructure that handles the operational demands so the owner can stay focused on building clinical relationships.

Purchasing power that changes what you can offer

One of the structural advantages of the Synchrocare franchise network is buying power. As a franchise owner, you access the pricing leverage of a large medical device distribution company, which directly affects your ability to compete on value in facilities where cost is a consideration alongside clinical performance.

That advantage is not available to the independent rep working outside a network. It is built into the Synchrocare franchise model from day one, and it grows as the network expands nationally through new franchise territories.

A portfolio that covers multiple clinical needs

Synchrocare’s portfolio spans twelve manufacturer partners covering orthopedic fixation, spine, extremity surgery, wound care, orthobiologics, regenerative medicine, and bone grafting. As a franchise owner, you represent a range of products broad enough to serve multiple surgical specialties within the same facility, which deepens your clinical relationships and increases your value to the hospitals and ambulatory surgery centers you work with.

Building a portfolio of that depth independently would take years of manufacturer negotiations, individual compliance agreements, and separate training programs for each product. The Synchrocare franchise model compresses that timeline by giving you access to an established, vetted portfolio from day one of your market entry.

Infrastructure that handles what takes solo reps off the field

Back-office operations, customer service, order management, and compliance administration consume time that a solo rep has to handle personally. Every hour spent on administrative tasks is an hour not spent in front of a surgeon or inside a facility. Synchrocare provides back-office and customer service support so that franchise owners stay focused on what generates territory value: clinical relationships, case support, and product adoption.

Combined with a comprehensive medical sales consultant training program covering product knowledge, anatomy, surgical technique, and the full regulatory compliance framework including the AdvaMed Code of Ethics, the Stark Law, the Anti-Kickback Statute, and the False Claims Act, the Synchrocare franchise model gives independent owners every operational advantage of a large company while preserving the ownership and entrepreneurial freedom of running their own business.

To learn more about the Synchrocare franchise opportunity, visit www.synchrocare.com/franchising.

Competency built in training degrades over time. This is not a reflection on the quality of a clinical team. It is a well-documented pattern in performance science, and it applies to surgical teams as directly as it applies to any other high-stakes professional environment. The question is not whether skill retention declines without reinforcement. It does. The question is what a well-designed refresher program does about it.

The surgical devices a team uses today are not the same devices they will use two years from now. New products enter the portfolio. Technique refinements change how existing instruments are used. Clinical evidence evolves. A team trained thoroughly at product launch and never retrained operates on a foundation that grows less reliable with every quarter that passes.

Where the gaps appear first

Skill degradation in clinical teams is rarely dramatic. It shows up in small hesitations, in the handling of instruments that are used less frequently, and in the responses to questions about indication criteria or technique rationale. A scrub tech who set up a procedure fifty times in the first year and ten times in the second retains the steps but loses the precision. A circulating nurse who received one in-service on a new device and no follow-up support fills gaps in knowledge with approximation.

These gaps rarely produce adverse events directly. They produce friction, inconsistency, and a quiet erosion of the team’s confidence in newer devices, which is often why adoption stalls after a promising initial launch.

What a structured refresher program delivers

A structured medical device refresher training program does three things that a one-time in-service cannot. It identifies where knowledge has drifted since the initial training. It reconnects clinical staff to the clinical rationale behind the device, not just the steps. And it creates a documented record of ongoing competency that supports hospital staff development programs and compliance requirements.

Synchrocare’s medical sales consultants are trained to provide ongoing in-service support beyond the initial product introduction. That includes technique refreshers, case study reviews, updated FAQ resources, and direct availability for clinical questions that arise during or between procedures. The model treats clinical support as a continuous responsibility, not a one-time obligation.

Refresher training as a patient safety investment

Regulatory frameworks increasingly tie device competency documentation to institutional accreditation and risk management. A facility whose staff competency records show initial training and nothing more is carrying a gap that a well-structured refresher program closes. For clinical educators and surgical services directors, the investment in structured refresher training is also an investment in demonstrable, auditable quality.

Synchrocare provides the resources to make that investment practical: technique guides, product brochures, case studies, and FAQs that can be used independently or as the basis for scheduled in-service sessions. Medical sales consultants coordinate directly with surgical teams to ensure the support is relevant to the procedures being performed and the devices in current use.

The clinical teams that maintain the strongest device competency over time are not the ones who trained hardest at launch. They are the ones whose training never fully stopped. Is yours one of them?

To learn more about Synchrocare’s clinical support and training resources, visit www.synchrocare.com.

Up to 67% of OR delays are attributed to equipment and supply issues.

That figure comes from published surgical efficiency research, and it reflects a reality that OR directors, surgical coordinators, and hospital administrators know from experience. The operating room is the most resource-intensive and time-sensitive environment in a healthcare facility. When the supply chain supporting it works well, it is invisible. When it does not, every minute of delay has a cost.

Medical device logistics is one of the most direct levers administrators have for improving OR performance. Choosing the right specialty medical device distributor is not a procurement decision in isolation. It is an operational one.

Inventory you can count on

A distributor with reliable order management and consistent supply keeps your instrument sets complete and your cases on schedule. Synchrocare provides back-office and customer service infrastructure specifically designed to support the post-sale operational needs of hospitals and ambulatory surgery centers.

That means predictable delivery, responsive account management, and a single point of contact who understands the facility’s product mix and the scheduling demands of its surgical teams.

Consignment and loaner set management

For facilities using consignment inventory or loaner instrument sets, the distributor’s logistical discipline directly affects OR readiness. Sets that arrive incomplete, late, or unchecked create delays that fall on clinical staff to resolve under pressure.

Synchrocare’s medical sales consultants are trained to support instrument set management as part of their clinical role, not as an afterthought. That operational engagement means fewer surprises on the day of surgery.

Compliance that protects the facility

Every vendor who enters your facility carries compliance implications for your institution. Distributor representatives who are not properly credentialed, insured, and trained on regulatory standards create exposure that lands on your compliance team.

Every Synchrocare medical sales consultant undergoes a thorough background check, maintains industry-standard insurance, and completes training on the AdvaMed Code of Ethics, the Stark Law, the Anti-Kickback Statute, and the False Claims Act before entering any facility. All activities are conducted in full compliance with applicable regulations and industry standards.

Clinical support that reduces administrative burden

When a new device is introduced into a facility, the burden of coordinating staff training, scheduling in-services, and managing questions from the surgical team typically falls on administrators and clinical educators. A distributor who provides comprehensive in-service support, technique guides, case studies, and ongoing clinical availability reduces that burden significantly.

Synchrocare provides these resources across every product in its portfolio. Medical sales consultants remain available for clinical support long after the initial product introduction, which means your team always has a knowledgeable point of contact when questions arise.

To learn more about how Synchrocare supports hospital and ASC operations, visit www.synchrocare.com.

The hand, wrist, foot, and ankle are the most mechanically active regions of the body. They absorb impact, generate force, and execute the fine movements people rely on for work, movement, and daily life. They are also, historically, among the most underserved areas in orthopedic device development.

Extremity Medical was founded in 2008 in Parsippany, New Jersey, with a focused mission: to develop next-generation products specifically for fusion, fixation, and motion preservation in the upper and lower extremities. The company was built by Matt Lyons and later joined by Mike Lyons, whose background includes establishing Blackstone Medical, a leading spine company. That entrepreneurial foundation shaped an organization with a driven culture and a consistent focus on engineering problems that matter to extremity surgeons.

The patented Post platform: mechanical advantage applied to extremity fixation

At the core of Extremity Medical’s innovation strategy is the patented Post platform technology. By leveraging the principle of mechanical advantage, the Post platform provides surgeons with unique fixation options designed to optimize compression and stability across a range of extremity procedures. The company describes this as pioneering a new treatment paradigm for extremity surgery, and the breadth of products built on this foundation reflects how extensively it has been applied.

Extremity Medical collaborates closely with leading surgeons and key institutions, analyzing complex clinical challenges and applying rigorous engineering principles to deliver solutions that are practical in the OR. The company’s state-of-the-art facility in Parsippany includes an in-house cadaver lab that supports product validation and surgeon training, hosting VIP surgeon visits and hands-on cadaver labs alongside didactic lectures and sales representative training.

Real Change Starts Here. That is not a tagline. It is the standard Extremity Medical holds every product to before it reaches the surgical field.

Lower extremity: a comprehensive procedure-matched portfolio

Across the foot and ankle, Extremity Medical offers products organized by procedure rather than by product type, which reflects how surgeons actually think about their cases. The portfolio covers ankle arthrodesis and fracture, forefoot procedures including hammertoe correction, Lapidus and TMT arthrodesis, and Chevron and Akin osteotomies, as well as hindfoot procedures including subtalar, TN, CC, and TTC arthrodesis and Charcot foot reconstruction.

Specific products include the IO FiX 2.0 intraosseous fixation system, the Express intraosseous screw system, the HammerFiX system for hammertoe correction, the Jones Union System for fifth metatarsal and Jones fractures, and the Cartilaginator for joint preparation. The Omni plating family covers Lapidus, mini, universal, and ankle fracture applications. For complex reconstruction, the Axis Beams and Axis Plates address the most demanding cases, including Charcot deformity.

Upper extremity: from finger to wrist

In the upper extremity, Extremity Medical’s portfolio addresses MCP and PIP arthrodesis as well as total wrist arthroplasty. The KinematX Total Wrist device has reached significant clinical milestones, with the 100th total wrist replacement performed at Duke University in North Carolina, demonstrating growing surgeon adoption at major academic institutions. The ApeX and XMCP systems extend fixation options across the hand and fingers.

A track record of innovation and patent protection

Extremity Medical has secured multiple patents covering its core technologies, including the IO FiX intraosseous fixation system and the SlotLock locking compression slot within an orthopedic plate, which provides greater sustained and peak compression. The company has successfully defended these patents against challenges, demonstrating the strength of its intellectual property position. Synchrocare distributes Extremity Medical products as part of its national specialty medical device portfolio, giving surgeons access to this technology through trained, compliant medical sales consultants.

To learn more about Extremity Medical products available through Synchrocare, visit www.synchrocare.com.

You know the product. You know the surgeons. You know the OR. You have spent years building the kind of clinical credibility that takes most people the better part of a decade to develop. The question is not whether you are good at medical device sales. The question is whether you are ready to run a business.

That distinction is what separates a successful medical device franchise owner from a high-performing rep who made the jump too early, or for the wrong reasons. The Synchrocare franchise model gives you the structure, the portfolio, and the infrastructure to make that transition with confidence. But the transition itself requires a clear understanding of what changes and what new demands it places on you.

The mindset shift that matters most

As a rep, your primary accountability is to your number. As a franchise owner, your accountability is to your business, which means your number, your compliance record, your team development, your clinical relationships, and the long-term value of the territory you are building. Those are not the same job.

Owners think differently about time. A rep prioritizes the next case and the next quarter. A franchise owner thinks about the next case and the next five years simultaneously. That longer lens changes how you invest in relationships, how you approach training, and how you make decisions when short-term revenue and long-term territory value point in different directions.

What the Synchrocare training program prepares you for

Every Synchrocare franchise owner completes a comprehensive medical sales consultant training program before entering the market. That program covers the full product portfolio, procedure-relevant anatomy, surgical technique considerations, and the complete compliance framework, including the AdvaMed Code of Ethics, the Stark Law, the Anti-Kickback Statute, and the False Claims Act. Background checks and insurance requirements apply across the entire network.

The training is not designed to teach you sales. It is designed to make sure you walk into every clinical environment prepared, credible, and compliant from day one. The franchise owners who build the strongest territories fastest are the ones who take that preparation seriously before they start, not after.

The infrastructure that comes with the model

As a Synchrocare franchise owner, you have access to an established portfolio of FDA-approved medical devices, national purchasing power, back-office and customer service support, and a network of owners operating to the same standard. You are not building from a blank page. You are entering a system designed to let you focus on what you do best, building clinical relationships and growing your territory, while the infrastructure around you handles the rest.

The three-step path is straightforward. Submit your application. Complete the training program. Enter the market as a principal in a network that is actively expanding nationally. What you build from that point is yours.

To learn more about the Synchrocare franchise opportunity, visit www.synchrocare.com/franchising.